High-resolution Diffusion-weighted Magnetic Resonance Imaging in Patients with Locally Advanced Breast Cancer

Academic Radiology

Volumn 19, Issue 5, 2012, Pages 526-534

  Singer, Lisa ^a   Wilmes, Lisa J ^a   Saritas, Emine U ^b   Shankaranarayanan, Ajit ^c   Proctor, Evelyn ^a   Wisner, Dorota J ^a   Chang, Belinda ^a   Joe, Bonnie N ^a   Nishimura, Dwight G ^b   Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Stanford University   (United States)

^c GE HEALTHCARE   (United States)

Author keywords

Apparent diffusion coefficient; Breast cancer; Diffusion weighted magnetic resonance imaging

Indexed keywords

ANTINEOPLASTIC AGENT; GADOLINIUM PENTETATE;

ADULT; ADVANCED CANCER; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORPHOLOGY; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE QUALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION FIELD; RADIOLOGIST; REDUCED FIELD OF VIEW; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; STANDARD;

ADULT; AGED; BREAST NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84859001402     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.11.003     Document Type: Article

References (31)

1. Park M.J., Cha E.S., Kang B.J., et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 2007, 8:390-396.
2. Yoshikawa M.I., Ohsumi S., Sugata S., et al. Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer. Radiat Med 2008, 26:222-226.
3. Pickles M.D., Gibbs P., Lowry M., et al. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006, 24:843-847.
4. Yankeelov T.E., Lepage M., Chakravarthy A., et al. Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging 2007, 25:1-13.
5. Sharma U., Danishad K.K., Seenu V., et al. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009, 22:104-113.
6. Iacconi C., Giannelli M., Marini C., et al. The role of mean diffusivity (MD) as a predictive index of the response to chemotherapy in locally advanced breast cancer: a preliminary study. Eur Radiol 2009, 20:303-308.
7. Fangberget A., Nilsen L.B., Hole K.H., et al. Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 2011, 21:1188-1199.
8. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006, 94:427-435.
9. Nilsen L., Fangberget A., Geier O., et al. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Acta Oncol 2010, 49:354-360.
10. Tozaki M., Oyama Y., Fukuma E., et al. Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Jpn J Radiol 2010, 28:101-109.
11. Jeong E.K., Kim S.E., Guo J., et al. High-resolution DTI with 2D interleaved multislice reduced FOV single-shot diffusion-weighted EPI (2D ss-rFOV-DWEPI). Magn Reson Med 2005, 54:1575-1579.
12. Wheeler-Kingshott C.A., Hickman S.J., Parker G.J., et al. Investigating cervical spinal cord structure using axial diffusion tensor imaging. Neuroimage 2002, 16:93-102.
13. Wilm B.J., Svensson J., Henning A., et al. Reduced field-of-view MRI using outer volume suppression for spinal cord diffusion imaging. Magn Reson Med 2007, 57:625-630.
14. Karampinos D.C., Van A.T., Olivero W.C., et al. High resolution reduced-FOV diffusion tensor imaging of the human pons with multi-shot variable density spiral at 3T. Conf Proc IEEE Eng Med Biol Soc 2008, 2008:5761-5764.
15. Sinha S., Sinha U. Recent advances in breast MRI and MRS. NMR Biomed 2009, 22:3-16.
16. Kuroki Y., Nasu K., Kuroki S., et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004, 3:79-85.
17. Saritas E.U., Cunningham C.H., Lee J.H., et al. DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med 2008, 60:468-473.
18. Saritas E, Shankaranarayanan A, Han E, et al. High-resolution DWI outside the CNS using reduced-FOV single-shot EPI. Presented at: 17th Annual Meeting of the International Society for Magnetic Resonance in Medicine; Honolulu, HI; 2009.
19. Li K.L., Partridge S.C., Joe B.N., et al. Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging. Radiology 2008, 248:79-87.
20. Partridge S.C., Gibbs J.E., Lu Y., et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002, 179:1193-1199.
21. Partridge S.C., Mullins C.D., Kurland B.F., et al. Apparent diffusion coefficient values for discriminating benign and malignant breast MRI lesions: effects of lesion type and size. AJR Am J Roentgenol 2010, 194:1664-1673.
22. Neil J.J. Measurement of water motion (apparent diffusion) in biological systems. Concepts Magn Reson 1997, 9:385-401.
23. Ge Y., Kolson D.L., Babb J.S., et al. Whole brain imaging of HIV-infected patients: quantitative analysis of magnetization transfer ratio histogram and fractional brain volume. AJNR Am J Neuroradiol 2003, 24:82-87.
24. Al-Saeed O., Ismail M., Athyal R.P., et al. T1-weighted fluid-attenuated inversion recovery and T1-weighted fast spin-echo contrast-enhanced imaging: a comparison in 20 patients with brain lesions. J Med Imaging Radiat Oncol 2009, 53:366-372.
25. Bland J.M., Altman D.G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1:307-310.
26. Oka K., Yakushiji T., Sato H., et al. The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient. Skeletal Radiol 2010, 39:141-146.
27. Sugahara T., Korogi Y., Kochi M., et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999, 9:53-60.
28. Murakami R., Sugahara T., Nakamura H., et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 2007, 243:493-499.
29. Zaharchuk G., Saritas E.U., Andre J.B., et al. Reduced field-of-view diffusion imaging of the human spinal cord: comparison with conventional single-shot echo-planar imaging. AJNR Am J Neuroradiol 2011, 32:813-820.
30. Pope W.B., Kim H.J., Huo J., et al. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology 2009, 252:182-189.
31. Tozer D.J., Jäger H.R., Danchaivijitr N., et al. Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR Biomed 2007, 20:49-57.